Telomir Pharmaceuticals, Inc. (TELO)

Price & Market Data

Price: $1.25

Daily Change: -$0.05 / 4.00%

Daily Range: $1.24 - $1.31

Market Cap: $88,719,696

Daily Volume: 53,956

Performance Metrics

1 Week: 0.79%

1 Month: -8.57%

3 Months: 13.27%

6 Months: -10.49%

1 Year: -39.91%

YTD: -7.91%

About Telomir Pharmaceuticals, Inc. (TELO)

Access real-time market insights for Telomir Pharmaceuticals, Inc. (TELO). The stock is trading at 1.25, reflecting a daily change of -$0.05 / 4.00%. With a market capitalization of 88,719,696, it showcases performance metrics including 6-month (-10.49%) and 1-month (-8.57%) returns.

Company Details

Employees: 2

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Selected stocks

Rekor Systems, Inc. (REKR)

Funko, Inc. (FNKO)

Chegg, Inc. (CHGG)

CDT Environmental Technology Investment Holdings Limited (CDTG)

iPower Inc. (IPW)